GLP-1 drugs and pregnancy: separating TikTok hype from real risk

What did @realdrbae actually say?

The creator made two separate arguments in this video. First, that semaglutide (Ozempic) can interfere with oral contraceptives, leading to unintended pregnancies. Second, that for people who wanted to get pregnant, semaglutide improved fertility by treating underlying PCOS and obesity. The conclusion was a strong one: "Semaglutide should be the first line treatment for PCOS and infertility." That last sentence is where this video goes off the rails, and it's worth separating the reasonable observations from the overreach.

The framing is anecdote-driven. The creator is drawing clinical conclusions from TikTok comment sections, not clinical trials. That's not nothing, since patient-reported outcomes matter, but it is a long way from evidence-based medicine.

Does the science back this up?

Partially, yes. The link between semaglutide, weight loss, and improved reproductive outcomes in people with PCOS is real and documented. Weight reduction alone is known to restore ovulation in a meaningful percentage of people with obesity-related anovulation. Semaglutide appears to accelerate that process. A 2023 study by Jensterle et al. in Diabetes, Obesity and Metabolism found semaglutide significantly reduced androgen levels and improved menstrual regularity in women with PCOS compared to placebo. A 2024 review in Frontiers in Endocrinology noted emerging evidence for GLP-1 receptor agonists as a metabolic intervention in PCOS, while explicitly cautioning that randomized controlled trial data supporting fertility outcomes specifically is still limited.

The birth control interaction claim also has a real mechanism behind it. Semaglutide slows gastric emptying, which can reduce absorption of oral contraceptives. Novo Nordisk's own prescribing information flags this. But the magnitude of that effect on real-world contraceptive failure rates is not well established.

What did they get wrong (or right)?

Here is what they got right: semaglutide can improve metabolic conditions that suppress fertility in people with PCOS and obesity. That is biologically plausible and increasingly supported by early clinical data. Framing it as treating an underlying condition rather than directly "curing infertility" is the correct framing, and they used it.

Here is the problem. The leap to "semaglutide should be the first line treatment for PCOS and infertility" is not supported by evidence. First-line status requires head-to-head superiority or non-inferiority data against existing treatments. Metformin has decades of data in PCOS. Letrozole and clomiphene have established roles in ovulation induction. Lifestyle intervention remains the foundation of PCOS management in clinical guidelines including those from the Endocrine Society (2023). Semaglutide has promising early signals, not a body of evidence that displaces any of those options.

Drawing clinical recommendations from comment sections is also a methodological problem worth naming plainly. Anecdotes cluster around people who had a positive experience. That is selection bias by design.

What should you actually know?

If you have PCOS and are considering semaglutide, the conversation to have is with a reproductive endocrinologist or OB-GYN, not a TikTok comment section. Weight loss through any mechanism, including GLP-1 receptor agonists, can restore ovulation in people with obesity-related anovulation. That is a legitimate reason to discuss semaglutide with a provider if you have PCOS and are struggling with weight.

Critically, if you are on semaglutide and do not want to become pregnant, this video's earlier point stands. The gastric emptying effect is real. Backup contraception or non-oral methods are worth discussing with your provider. Semaglutide is also explicitly contraindicated in pregnancy, per FDA labeling. The prescribing information recommends stopping it at least two months before a planned pregnancy attempt.

• Semaglutide is not approved to treat PCOS or infertility.
• It is not a first-line fertility treatment by any current clinical guideline.
• Early data is promising, but promising is not the same as proven.
• If you are trying to conceive, stopping semaglutide at least two months before is the current recommended approach.